Literature DB >> 35226288

Is robotic lobectomy cheaper? A micro-cost analysis.

Ben Shanahan1,2, Usha S Kreaden3, Jan Sorensen4, Steven Stamenkovic5, Karen C Redmond6,7.   

Abstract

Higher capital costs and operating room costs associated with Lobectomy via Robot Assisted Thoracic Surgery (RATS) have previously been suggested as the principal contributors to the elevated overall cost. This study uses a micro-costing approach to a previous analysis of clinical outcomes of RATS, Video-Assisted Thoracic Surgery (VATS) and Open Lobectomy to evaluate the most significant cost drivers for the higher cost of robot-assisted lobectomy. A micro-costing model was developed to reflect the pathway of patients from day of surgery through the first 30 days following lobectomy. Costs were provided for RATS, VATS and Open approaches. Sensitivity analysis was performed specifically in the area of staff costs. A threshold sensitivity analysis of the overall cost components was also performed. Total cost per case for the RATS approach was €13,321 for the VATS approach €11,567, and for the Open approach €12,582. The overall cost differences were driven primarily by the elevated consumable costs associated with RATS Lobectomy. Capital costs account for a relatively small proportion of the per-case cost difference. This study presents a detailed analysis of the cost drivers for lobectomy, modelled for the three primary surgical approaches. We believe this is a useful tool for surgeons, hospital management, and service commissioning agencies to accurately and comprehensively determine where cost savings can be applied in their programme to improve the cost-effectiveness of RATS lobectomy.
© 2022. The Author(s).

Entities:  

Keywords:  Cost analysis; Healthcare economics; Lobectomy; Robotic surgery; Thoracic surgery

Year:  2022        PMID: 35226288     DOI: 10.1007/s11701-022-01377-x

Source DB:  PubMed          Journal:  J Robot Surg        ISSN: 1863-2483


  1 in total

1.  Comparison of health-care utilization and expenditures for minimally invasive vs. open colectomy for benign disease.

Authors:  Sarah E Diaz; Yongjin F Lee; Amir L Bastawrous; I-Fan Shih; Shih-Hao Lee; Yanli Li; Robert K Cleary
Journal:  Surg Endosc       Date:  2022-02-22       Impact factor: 3.453

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.